Monica Agar, MD
Obstetrics & Gynecology · Westampton, NJNPI 1790711497
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Innocoll Pharmaceuticals Limited at 54.1% of the total. Reporting peaked in 2021 at $611 and has fallen 96.6% since, to $21 in 2025.
Across 28 payments — averaging $37.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innocoll Pharmaceuticals Limited$575
- Astellas Pharma US Inc$110
- AMAG Pharmaceuticals, Inc.$67
- AbbVie$61
- Hologic Sales And Service, LLC$55
- Therapeuticsmd, Inc.$41
- plus $154 from 8 others
What the payments were for
- Consulting fees$57554%
- Food & beverage$33031%
- Education$15715%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innocoll Pharmaceuticals Limited | 1 | $575 |
| Astellas Pharma US Inc | 2 | $110 |
| AMAG Pharmaceuticals, Inc. | 5 | $67 |
| AbbVie(2 entities) | 5 | $61 |
| Hologic Sales And Service, LLC | 2 | $55 |
| Therapeuticsmd, Inc. | 3 | $41 |
| Amgen | 2 | $29 |
| Millicent US Inc | 2 | $27 |
| Avanos Medical | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Mission Pharmacal Company | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARACOLL$575
How this compares
$1,062 in reported general payments places this provider in the 60th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 50 | $3,872 |
| ValacyclovirValacyclovir Hcl | 15 | $648 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Westampton
- Jennifer AshtonEnglewood$1.5M
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Paula JasionowskiVoorhees$193K
- Justin ChuraSwedesboro$179K
- Andrea VentolaFlorham Park$145K
- Aiman ShiladPaterson$100K
- Patrick CulliganMorristown$93K
- Dipak DelvadiaCherry Hill$86K
- Susan PitmanWest Orange$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.